CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	5 Months Ended	6 Months Ended
	Feb. 11, 2023	Feb. 12, 2022
Cash flows from operating activities:
Net income	$ 1,015,862	$ 1,026,990
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and equipment	222,964	199,282
Other non-cash charges	91,000
Amortization of debt origination fees	3,922	5,373
Deferred income taxes	(4,697)	40,983
Share-based compensation expense	42,379	30,738
Changes in operating assets and liabilities:
Accounts receivable	22,273	(27,385)
Merchandise inventories	(161,546)	(393,459)
Accounts payable and accrued expenses	(111,311)	278,833
Income taxes	87,400	12,774
Other, net	(60,185)	(34,383)
Net cash provided by operating activities	1,148,061	1,139,746
Cash flows from investing activities:
Capital expenditures	(259,234)	(208,143)
Purchase of marketable debt securities	(14,000)	(22,632)
Proceeds from sale of marketable debt securities	3,450	13,908
Investment in tax credit equity investments	(12,070)	(20,656)
Proceeds from disposal of capital assets and other, net	11,846	26,210
Net cash used in investing activities	(270,008)	(211,313)
Cash flows from financing activities:
Net proceeds from commercial paper	227,600	1,068,100
Proceeds from issuance of debt	1,000,000
Repayment of debt	(300,000)	(500,000)
Net proceeds from sale of common stock	72,758	66,457
Purchase of treasury stock	(1,799,997)	(2,459,995)
Repayment of principal portion of finance lease liabilities	(40,572)	(31,100)
Other, net	(4,510)	(3,362)
Net cash used in financing activities	(844,721)	(1,859,900)
Effect of exchange rate changes on cash	3,574	(445)
Net increase/(decrease) in cash and cash equivalents	36,906	(931,912)
Cash and cash equivalents at beginning of period	264,380	1,171,335
Cash and cash equivalents at end of period	$ 301,286	$ 239,423